Havlik JL

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA.

3 papers · ORCID

ArticlePsilocybin

Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders.

Havlik JL, Isaac S, Raman P +3

Europe PMC2025
ArticleKetamine

Recent Advances in the Treatment of Treatment-Resistant Depression: A Narrative Review of Literature Published from 2018 to 2023.

Havlik JL, Wahid S, Teopiz KM +3

Europe PMC2024
ArticleKetamine

Characteristics of Esketamine Prescribers Among Medicare Beneficiaries in the United States, 2019-2020.

Havlik JL, Murphy MJ, Gong N +2

Europe PMC2023